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OBJECTIVE: Functional magnetic resonance imaging and transcranial magnetic stim-
ulation studies suggest that human cortex shows evidence of neuroplasticity. Preclin-
ical studies in rats and monkeys suggest that motor cortical stimulation can enhance
plasticity and improve recovery after stroke. This study assesses the safety and prelim-
inary efficacy of targeted subthreshold epidural cortical stimulation delivered concur-
rently with intensive rehabilitation therapy while using an investigational device in
patients with chronic hemiparetic stroke.
METHODS: This is a prospective, multicenter, and nonblinded trial randomizing
patients to rehabilitation with or without cortical stimulation. Patients aged 20 to 75
years who had had an ischemic stroke at least 4 months previously causing persistent
moderate weakness of the arm were included. Functional magnetic resonance imaging
localized hand motor function before surgery to place an epidural cortical electrode.
Both groups then underwent rehabilitation for 3 weeks after which the electrode was
removed. Outcome measures were obtained at baseline, during therapy, and at 1, 4,
8, and 12 weeks postprocedure.
RESULTS: Ten patients were randomized; six patients to surgery, four to the control
group. No patient deaths, neurological deterioration, or seizures occurred. There were
two infections from nonprotocol-related causes. Of the eight patients completing the
treatment, the stimulation plus rehabilitation group improved significantly better than
controls in the Upper Extremity Fugl-Meyer (P  0.003 overall) and the hand function
score of the Stroke Impact Scale (P  0.001 overall).
CONCLUSION: The technique of cortical stimulation to enhance stroke recovery is
well tolerated and safe.
KEY WORDS: Cortical stimulation for stroke recovery, Electrical stimulation, Motor cortex, Rehabilitation,
Stroke
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Stroke is the third leading cause of death and the mostcommon cause of disability in the United States. Thereare approximately 700,000 strokes in the United States
annually, with approximately 150,000 to 250,000 stroke survi-
vors becoming severely and permanently disabled. There are
over 5 million disabled stroke survivors. The most common
neurological deficit among these stroke survivors is weakness,
which contributes to poststroke disability. The only approved
available treatment showing benefit for patients with residual
motor deficits is physiotherapy. Unfortunately, many patients do
not achieve complete recovery after rehabilitation therapy (10).
Spontaneous recovery does occur after stroke, possibly from
recovery of marginally effective cortical areas with limited or
temporary insult. Alternatively, neurological restoration may
be from reorganization, in which adjacent brain areas take
over the function of stroke-damaged areas. The latter mecha-
nism falls under the concept known as neuroplasticity.
There is an extensive clinical literature on motor cortex
stimulation for central and peripheral neuropathic pain syn-
dromes beginning with the work of Tsubokawa et al. (24, 26)
in 1991. The authors commented on the motor effects of cor-
tical stimulation for treatment of neuropathic pain in this
publication and in ensuing related publications, noting, sub-
jective improvement of motor deficits was also reported in
most of these cases. Similar findings have also been seen in
ensuing clinical studies for the treatment of central and neu-
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ropathic pain syndromes. A number of laboratory investiga-
tions confirm these observations of enhanced motor recovery
brought about by cortical stimulation during rehabilitation
from stroke (1, 15, 21, 23).
This study tests the hypothesis that subthreshold cortical
stimulation of primary motor cortex involved in producing
residual motion in an impaired limb after a nonhemorrhagic
cortical or subcortical infarction may enhance motor recovery.
This feasibility study is designed to assess the safety of tar-
geted subthreshold electrical motor cortex stimulation deliv-
ered to stroke patients concurrent with active rehabilitation.
The primary objective is to establish the safety of this tech-
nique while also obtaining preliminary efficacy data.
METHODS
Overall Design
This is a prospective, randomized, multicenter study of the
safety of subthreshold motor cortical electrical stimulation of
patients with motor deficit resulting from a stroke that oc-
curred at least 4 months before enrollment. The study was
supported by Northstar Neuroscience (Seattle, WA). Patients
were randomized into two groups: 1) a treatment group that
underwent an electrode (a 3  3 grid electrode, Ad-Tech,
Racine, WI) implant and subsequent epidural electrical stim-
ulation (at 50 Hz, 50% of the current needed to evoke gross
motor movement) using an investigational battery powered
external pulse generator (Northstar Neuroscience, Seattle,
WA) concurrent with 3 weeks of rehabilitation (the investiga-
tional arm) and 2) a group of control stroke patients who
received the same 3 weeks of rehabilitation but did not un-
dergo device implantation. For the patients receiving cortical
stimulation, the stimulation device was turned on only during
rehabilitation therapy sessions. At other times, the external
stimulator was disconnected, and no stimulation was deliv-
ered. All patients received 16 weeks of assessments, including
baseline, during 3 weeks of therapy, and for 12 weeks after the
end of rehabilitation therapy.
Subjects
Subjects were recruited after approval of each institution’s
institutional review board and after an appropriate informed
consent had been signed. The major inclusion and exclusion
criteria are given in Table 1.
Protocol
Patients who, after preliminary screening, were deemed
candidates for inclusion in this study then underwent func-
tional magnetic resonance imaging (fMRI) using a protocol to
evaluate the cortical activation associated with finger tapping
or movement of the paretic hand at least 5 degrees at the wrist.
These images were evaluated to determine whether the pa-
tient had sufficient activation to identity the primary motor
cortex of the affected hemisphere. If an activation site within
primary motor cortex was found, the voxel of greatest activa-
tion within the largest motor cortex activation cluster was
identified (4), and then the patient was randomized into either
1) the treatment group or 2) the control group. If no activation
was seen, the subject did not continue with the study.
Surgery
The site for hand function was identified on the fMRI before
surgery. On the day of surgery, fiducials were placed, and a
T1-weighted MRI was performed (Fig. 1). This activation site
was integrated into a neuronavigational workstation. General
endotracheal anesthesia was induced. Patients were posi-
tioned supine with the head rotated to the side. Electromyo-
graphy electrodes were inserted in the affected shoulder, arm,
and hand for intraoperative cortical mapping. The site corre-
sponding to hand function was mapped onto the scalp using
neuronavigation. After this localization, an appropriate scalp
incision was performed so that a circular 4 cm craniotomy
could be centered over the center of the fMRI activation site.
Once the bone flap was removed, this activation site was
projected onto the exposed dura. In preparation for epidural
cortical stimulation, the general anesthesia was allowed to
lighten to the minimal necessary to keep the patient uncon-
scious. Muscle paralyzing agents were not used except during
induction. Transdural electrical stimulation at 50 Hz was then
undertaken with the objective of evoking either gross motor
movement or electromyographic activation of the hand/finger
electrodes. This stimulation was intended to verify that the
underlying cortex was capable of evoking peripheral muscle
activity but not to supplant the role of fMRI in selecting the
site for electrode placement. The initial electrode orientation
TABLE 1. Major inclusion and exclusion criteria
Major inclusion criteria:
Patients 20 to 75 years.
Ischemic infarct, either cortical or capsular, that occurred at
least 4 months before enrollment and demonstrated on
computerized tomography or magnetic resonance imaging.
An Upper Extremity Fugl-Meyer Assessment score between
20 and 50, inclusive sufficient to allow active wrist extension
of at least 5 degrees.
Major exclusion criteria:
Another stroke preceded their index stroke and was
associated with incomplete motor recovery.
There was a history of spinal cord injury, significant
traumatic brain injury (such that associated with loss of
consciousness and memory loss), or a subdural or epidural
hematoma.
They had any history of seizures or were taking
anticonvulsants to treat seizures.
There was any significant central nervous system disease
state.
They were not considered candidates for surgery to implant
the device.
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was estimated so that the long axis of the electrode was at
right angles to the suspected trajectory of the central sulcus.
After completion of epidural stimulation, the investiga-
tional electrode grid was sutured to the dura with the center of
the grid over the point deemed to be the center of the fMRI
hot spot (4). The electrode lead was tunneled to a supracla-
vicular exit site and the bone flap replaced. Patients were
observed in intensive care for 24 hours after surgery and
discharged on the second postoperative day. Rehabilitation
began 1 week later.
After the rehabilitation portion of the protocol was com-
pleted, the patient’s craniotomy wound was reopened under
general anesthesia for removal of the investigational device.
This second surgery did not require recovery in the neurosur-
gical intensive care.
Control Patients
Patients in this group did not undergo device implantation
but were started on the same rehabilitation protocol as the
treatment patients.
Rehabilitation
All study patients were given the same active rehabilitation
protocol, which required two 1.5 hour sessions per day, 5 days
a week, for a total of 3 weeks. This occupational therapy was
directed toward strengthening and improving function of the
affected shoulder/arm/hand. All rehabilitation, with or with-
out electrical stimulation, was provided under the direct su-
pervision of a therapist.
Electrical Stimulation
At the beginning session each week of treatment, threshold
for evoking gross movement in the contralateral hand was
determined using stimulation parameters of 3 second trains of
50 Hz, 250 ms pulses starting at 1 mA and increasing until
either movement was evoked or a maximum of 15 mA was
reached.
At the beginning of each rehabilitation session, stimulation
was turned on. Stimulation was set at either 50% of movement
threshold (if movement was evoked) or 6.5 mA (if no move-
ment was evoked) and supplied through the outermost two
rows of electrodes, one side serving as cathode, the other side
serving as anode, with the middle electrode row not being
used for stimulation. Biphasic stimulation pulses were deliv-
ered with 250 ms first-phase durations and decaying exponen-
tial second phases. Stimulation was turned off upon comple-
tion of each rehabilitation session.
Outcome Measures
The numerous outcome measures chosen for this initial
feasibility study are listed in Table 2. The primary focus was
safety, and so patient status and potential adverse events were
carefully monitored. Neurological status was measured via
several scales, on numerous occasions. The most important
scales used were the Upper Extremity Fugl-Meyer (UEFM)
scale, the Stroke Impact Scale, and the ArmMotor Ability Test.
Both patient groups were tested before randomization (base-
line), during each week of treatment, and during follow-up
physician visits at 1, 4, 8, and 12 weeks after the last rehabil-
itation session. Outcome assessments were unblinded.
Safety
The primary endpoint of this study was safety. Safety was
defined by measuring the proportion of patients who had any
of the following outcomes between the time of enrollment and
the time that electrode was removed (approximately 23–28 d
later): 1) death, 2) medical morbidity, including myocardial
infarction, pneumonia, wound infection, or deep venous
FIGURE 1. Example of patient
fMRI activation target selection in a
patient with a cortical infarct in left
primary sensory cortex.
TABLE 2. Outcome measures
Measures of motor impairment:
Upper Extremity Fugl-Meyer Scale
Grip strength
Action Research Arm test (ARM)
9-hole Pegboard Test
Tapping speed
Stroke scales:
National Institutes of Health Stroke Scale (NIHSS)
Stroke Impact Scale (SIS)
Activities of daily living
Functional Independence Measure (FIM)
Neurological measures:
Neurological Function questionnaire
Mental status
Beck Depression Inventory
BROWN ET AL.
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thrombosis, 3) clinically definite generalized tonic-clonic sei-
zure, or 4) decrement in neurological status, defined as a
decrease in 20% on either the UEFM scale or the hand function
subscore of the Stroke Impact Scale.
At baseline, the patient’s medical condition was evaluated
by assessing the history, performing a neurological examina-
tion, obtaining a laboratory screen, electrocardiogram, chest
radiograph, electroencephalogram, and brain MRI. Neurolog-
ical status was evaluated on the final day of rehabilitation.
Any morbidity including seizure incidence was reported im-
mediately for review by the study’s independent data and
safety monitor board.
Statistics
For safety measures, descriptive statistics were used. For
assessment of neurological status, data were analyzed in two
different ways; note that specific scores on the UEFM scale
and Stroke Impact Scale hand subscale, and not percentage
change, were used in these analyses. First, longitudinal effects
were analyzed using repeated measures analysis of variance,
examining the time  treatment group interaction. As an
extension of examining longitudinal effects, an intention to
treat analysis was performed using a mixed linear model, a
generalization of standard linear model designed for analyz-
ing repeated measurements, via the SAS Proc Mixed proce-
dure (Cary, NC). Second, group characteristics were com-
pared at three prespecified time points: study week 4 (1 wk
follow-up after completion of treatment), the time point of
greatest interest, as well as at baseline and at study week 16
(12 wk follow-up after completion of treatment). These com-
parisons used a t test for continuous data and Fisher’s exact
test for proportions. All statistical tests were conducted at the
P  0.05 significance level.
RESULTS
Patients
A total of 14 patients were enrolled, but 4 were excluded
before randomization because they did not meet inclusion
criteria. Ten patients met full inclusion criteria and were ran-
domized, six patients to the treatment group and four patients
to the control group. Two treatment patients were withdrawn
from the study during week 1 of treatment because of com-
plications in their treatment (see below). Eight patients (4
treatment, 4 control) completed the study (Table 3). Five pa-
tients were male. Three patients were female. Mean age was 58
years with a range of 33 to 74 years. There were no significant
differences between treatment groups. All patients had suf-
fered a cortical or subcortical ischemic cerebral infarction be-
tween 9 and 68 months before entering the study. The mean
time between stroke and randomization was 28 months (range
9–68 mo). The infarction occurred in the right hemisphere for
four patients and in the left hemisphere for four patients.
Three surgery patients received implants on their right hemi-
sphere, whereas one surgery patient received an implant on
the left hemisphere.
Complications and Safety
No patient deaths occurred. No patient demonstrated new
neurological deficits during the period of assessment. There
were no seizures during study participation for any patient, in
either study group.
Two complications occurred, both infectious. One acute in-
fection resulted from a surgical protocol violation. Instead of
being tunneled to a supraclavicular exit site, the lead was
tunneled only to within 2 cm of the craniotomy wound. The
second complication was an electrode lead breakage caused
by tension on the electrode lead. Rather than risk reimplanta-
tion, the electrode was removed and the patient taken off
active treatment. This patient subsequently fell and traumati-
cally reopened the wound, resulting in an infection, which
was treated effectively. Thus, of six surgical patients, two
patients were excluded from the efficacy statistics.
Safety was also assessed by looking for a decline in motor
status during the 16 weeks of study assessments, using the
Fugl-Meyer arm motor score. Compared with baseline Fugl-
Meyer score, none of the patients randomized to cortical stim-
ulation had a 10% or greater decline at any of the follow-up
TABLE 3. Baseline patient characteristicsa
Overall (n  8) Investigational (n  4) Controls (n  4) P value
Sex 5 M, 3 F 2 M, 2 F 3 M, 1 F 1.0
Age (yr) 58  16 (33–74) 58  17 (34–74) 58  18 (33–73) 1.0
Months since stroke 28  20 (9–68) 18  18 (9–33) 38  24 (15–68) 0.2
Upper Extremity Fugl-Meyer 38  7 (24–48) 36  9 (24–43) 41  5 (38–48) 0.4
Hand Stroke Impact Scale 24  18 (0–60) 23  26 (0–60) 26  14 (5–35) 0.8
Beck Depression Inventory 8.3  6.0 (1–18) 6.8  5.9 (1–15) 9.8  6.7 (3–18) 0.5
Modified Rankin 2.1  0.6 (1–3) 2.0  0.8 (1–3) 2.3  0.5 (2–3) 0.6
Handedness 6 right, 2 left 4 right, 0 left 2 right, 2 left 0.4
Stroke affected brain hemisphere 4 right, 4 left 1 right, 3 left 3 right, 1 left 0.5
aM, male; F, female. Values are mean  SD. The mean time from stroke to study enrollment was more than twice as long in the control group (15, 22, 46, and 68
months) as compared with the investigational group (9, 11, 18, and 33 months). However, this difference was not significant.
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periods. However, one stroke patient randomized to the con-
trol intervention (physical therapy only) had a 16% decline
during follow-up. As an additional means of addressing this
issue, Fugl-Meyer scores were also compared from each visit
to the next. None of the patients randomized to the cortical
stimulation group had a 10% or greater decline in the arm
motor Fugl-Meyer score at any of the follow-up visits. On the
other hand, one control patient had a 16% decline at follow-up
week 1, and another control patient had a 13% decline at
follow-up week 4.
Efficacy Assessments
From baseline to study week 16, the UEFM score in the
investigational study group (n  4) improved by 10 points,
compared with only 1.9 points for the control group (P 0.05)
(Table 4). Repeated measures analysis of variance was P 
0.0001 overall, P  0.08 by time, and P  0.02 for the group 
time interaction. Scores for the UEFM results are presented in
Figure 1, which demonstrates that patients in the investiga-
tional active treatment (rehabilitation with cortical stimula-
tion) group improved to a significantly greater degree than
control patients (rehabilitation only). Furthermore, patients in
the active treatment group continued to improve through the
3 week treatment period into the 1 week follow-up assessment
(study week 4). Improvements were maintained through the
12 week follow-up assessment (study week 16). In compari-
son, lesser improvements in control patients occurred within
the first 2 weeks and then seemed to decrease over time (Fig.
1).
In an intention to treat analysis, scores were also analyzed
using all available serially collected Fugl-Meyer data for all 10,
rather than just 8, patients (i.e., including all available data
from the 2 patients who dropped out of the study because of
infection). The difference between treatment groups remained
significant (P  0.027).
Correlation between fMRI and Cortical Stimulation
Five of the six investigational patients were able to have
muscle activity evoked in the contralateral arm/hand by di-
rect epidural stimulation over the neuronavigationally deter-
mined center of the fMRI hot spot at the time of craniotomy
for electrode placement. Stimulation parameters for evoking
distal, contralateral muscle activity are shown in Table 5. Be-
cause patients were under general anesthesia, the current
levels were sometimes quite high. However, the type of
evoked movements were characteristic of stimulation of pri-
mary motor cortex and often consisted of individual finger
movements or simultaneous flexion of several fingers. In other
words, the accuracy of the fMRI for identifying motor cortex in
these patients was confirmed for five of six patients. Because
the depth of anesthesia could not be controlled, the reason for
the lack of response in the sixth patient could not be deter-
mined.
DISCUSSION
Stroke remains a major source of disability. There are cur-
rently few options to promote return of strength medically.
Reports of motor gains during epidural stimulation of motor
cortex for chronic poststroke pain suggested the current ap-
proach. The results suggest that this approach might provide
significant gains. The safety assessments were significant for
two infections, which, although explained by a protocol vio-
lation and a faulty electrode lead, nevertheless suggest the
need to carefully collect safety data in any future studies of
this approach.
Early clinical studies of the effectiveness of motor cortex
stimulation focused on reduction in central pain arising from
thalamic infarction or neuropathic pain arising from trigemi-
nal nerve injury (6, 8, 11–14, 16, 18–20, 22, 24–27). The authors
of these studies hypothesized that motor improvement was
secondarily observed to occur because of improvement in the
spasticity associated with the patient’s stroke. Hosobuchi et al.
(11) described a 53-year-old man with right hemiparesis, dys-
arthria, and bulbar pain 3 years after his stroke. Despite not
achieving satisfactory analgesia from the motor cortex stimu-
lation, this patient chose to have the stimulator internalized
because [he] was so pleased with the marked improvement in
his motor weakness. In a later review, Katayama et al. (13)
quantified the motor improvement that was observed with
TABLE 4. Upper Extremity Fugl-Meyer (A) and Hand Stroke Impact Scale (B) results by study groupa
(A) UEFM Baseline score Study week 4 (1 week follow-up) score Study week 16 (12 week follow-up) score
Investigational 35.3  7.8 (24.0–42.0) 45.5  10.8 (30.0–53.0) 45.3  9.7 (32.0–53.0)
Control 40.6  5.3 (36.0–48.0) 44.5  12.0 (34.0–60.0) 42.5  8.9 (34.0–52.0)
P valueb 0.12 0.047
(B) Hand SIS Baseline score Study week 4 (1 week follow-up) score Study week 16 (12 week follow-up) Score
Investigational 26  14 (5–35) 70  40 (10–95) 69  34 (20–95)
Control 23  26 (0–60) 51  29 (25–90) 46  33 (25–95)
P valueb 0.3 0.2
a UEFM, Upper Extremity Fugl-Meyer; SIS, Stroke Impact Scale.
b Comparison in improvement from baseline between investigational and control patients by t test. Values are mean  SD.
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motor cortex stimulation. In 19% of patients who underwent
epidural cortical stimulation for pain control, motor cortex
stimulation improved their hemiparesis. The benefit was
thought to be unrelated to the extent of pain control. Garcia-
Larrea et al. (8) reported that this effect might be caused by a
not quantified relief of spasticity during motor cortex stimu-
lation in some of their patients with strokes. Franzini et al.
(7) observed diminished stroke-related dystonia and inten-
tional myoclonus with motor cortex stimulation along with
pain relief. Four patients experienced pain control associated
with reduced intentional myoclonus. These findings are con-
sistent with Katayama et al.’s clarification that there was a
significant reduction in effective pain relief when there was
moderate or severe weakness in the painful region targeted.
Satisfactory pain control was achieved in 73% of the patients
in whom motor weakness in the painful region was absent or
mild but only in 15% of the patients who had moderate or
severe weakness in the painful region (13). The effects of
motor cortex stimulation are thus mediated through the motor
system.
A number of centers have since undertaken preclinical stud-
ies to confirm the benefits observed anecdotally in motor
recovery. Adkins-Muir and Jones (1) studied the effect of
perilesional, subdural motor cortex stimulation on a skilled
forelimb task in rats with ischemic cortical injury. Low-
frequency intermittent stimulation during poststroke rehabil-
itation significantly improved the forelimb retrieval task. Per-
formance levels persisted when tested 2 days after stimulation
was discontinued. Dendritic density in layer V of the peri-
lesion cortex also increased. Kleim et al. (15) investigated the
hypothesis that after a focal ischemic cortical infarction, motor
cortex stimulation combined with rehabilitation expands the
cortical representation of contralateral forelimb movement.
Rats with an ischemic cortical infarct underwent 50 Hz cortical
stimulation at 50% of the threshold for limb movement while
the accuracy of achieving reaching tasks was measured. Cor-
tical stimulation significantly enhanced motor recovery and
increased the area of peri-infarct cortex from which micro-
stimulation movements could be evoked. Teskey et al. (23)
used an alternate model of cerebral ischemia and also im-
planted recording electrodes for measuring frontal evoked
potentials. Addition of cortical stimulation to rehabilitative
training improved behavioral status and enhanced evoked
potentials and also reduced the amount of current required to
elicit a movement in a stimulation frequency dependent man-
ner.
Plautz et al. (21) used a primate model of cortical ischemic
infarction to investigate the benefits of motor cortex stimulation.
These authors mapped the proximal forelimb motor cortex (M1)
region using intracortical microstimulation techniques. An in-
farct was created using bipolar electrocoagulation over the neu-
rophysiologically identified M1 hand representation regions of
the squirrel monkeys. After 3.5 to 5 months, spontaneous motor
recovery had stabilized, although significant motor impairments
persisted. Cortical stimulation was combined with rehabilitative
training for 2 to 4weeks. Pellet retrieval from small wells showed
statistically significant gains although not to pre-infarct abilities.
Cortical mapping showed that therewas a significantly increased
hand representational area, with newly emerged hand represen-
tations apparent adjacent to the infarct as well as at a consider-
able distance from the infarct. This study is important because is
FIGURE 2. Changes in UEFM scores for the control and investigational
patient groups. Group means and standard deviations. A, raw scores show
greater gains in investigational group, but initial deficits were more severe
in this group. Repeated measures analysis of variance was P  0.0001
overall, P  0.08 by time, and P  0.02 for the group  time interaction.
B, greater gains in investigational group can be appreciated by presenta-
tion of data as percentage improvement in the UEFM score.
TABLE 5. Stimulation parameters for evoking contralateral
distal muscle activity by epidural stimulation over the
functional magnetic resonance imaging identified area of
motor cortex in six patientsa
Subject
Frequency
(Hz)
Pulse
duration
(ms)
Amplitude
(mA)
Train
duration
(sec)
1 400 500 35 0.005
2 50 300 15 3
3 50 400 17.5 5
4 No MEP/movement
5 50 250 15 3
6 400 500 30 0.005
a MEP, motor evoked potential.
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demonstrates that poststroke motor gains can be achieved out-
side of the subacute poststroke period.
These findings support the hypothesis that increased motor
cortical representation derives from enhanced synaptic func-
tion and restoration of cortical circuitry brought about by
cortical stimulation with rehabilitation. These preclinical stud-
ies when combined with the extensive clinical literature of
enhanced motor function that occurs during cortical stimula-
tion for central pain provide the background for a clinical
investigation of the safety of enhancing outcome after non-
hemorrhagic stroke in humans (3).
Bezard et al. (2), in 1999, published a primate study assess-
ing the potential risk of inducing epileptic seizures using
chronic motor cortex stimulation parameters similar but for a
greater duration than parameters proposed in this clinical
trial. The primate study used chronic motor cortex stimulation
parameters similar to what is used to relieve chronic pain. In
this study, none of the primates developed epileptic seizures
at the stimulation parameters (i.e., frequency and pulse dura-
tion of approximately 40 Hz and 90 s, respectively, and at a
subthreshold intensity for inducing muscle movement). Sei-
zures could only be induced at intensities approximately twice
as high as necessary to evoke motor movement. Although
cortical reorganization is hypothesized to be the explanation
for this improvement, the precise mechanism for this enhance-
ment of function is not yet known.
Another possible explanation is the inhibition during stim-
ulation of regions that have developed hyperactivity after
stroke and confound effective motor function or retraining.
For example, Tsubokawa et al. (25) noted inhibition of tha-
lamic hyperactivity by motor cortex stimulation in a cat deaf-
ferentation model wherein the spinothalamic tract had been
sectioned. Garcia-Larrea et al. (8, 9) observed regions of in-
creased blood flow when positron emission tomographic
scans were performed during motor cortex stimulation of
patients with central pain syndromes. The most significant
increase in regional cerebral blood flowwas seen in the ventral
lateral thalamus, probably reflecting corticothalamic connec-
tions from motor areas. This could reflect direct enhancement
of motor output or secondary enhancement of this region from
inhibition of other regions. It is not yet clear how the hypoth-
esis of thalamic electrophysiological inhibition fits in with
these identified sites of increased regional cerebral blood flow.
It appears both from preclinical studies and the current
study that the enhancement of function persists after with-
drawal of cortical stimulation. This observation suggests that
the motor improvement represents more than direct enhance-
ment of surrounding marginally functional cortical neurons. It
also suggests that the improvement is not simply an indirect
result of inhibition of confounding regions of hyperactivity.
During intraoperative cortical mapping, individual finger con-
tractions occurred, movements that were not present before
stimulation through voluntary effort. The combination of re-
habilitation and stimulation may enhance the plasticity of
marginally effective circuits, leading to improved voluntary
function.
The primary goal of this study is to demonstrate the safety
of this procedure. Most importantly, there was no deteriora-
tion in neurological function observed from the surgery to
implant a cortical stimulating electrode. The two groups were
well randomized (Table 3). Although a trend (P  0.20) fa-
vored earlier time poststroke for enrollment of the experimen-
tal group, these subjects were more than a year beyond the 3
month interval poststroke generally considered to represent
the main time of behavioral recovery plateau (5, 17). An ad-
ditional weakness was the lack of blinding during outcome
assessments in patients with versus without craniotomy.
Blinding could be added to future studies in several different
ways. For example, each investigational group patient could
serve as his/her own control by comparing results when the
device is switched on with results when device is switched off.
Alternatively, raters blinded to patient treatment group could
be used to assess motor status.
Two patients developed an infection during study partici-
pation, one in association with a protocol violation and the
second in association with a faulty lead. These complications
do not likely portend a high infection rate for future applica-
FIGURE 3. Changes in Hand Function Subscore of the Stroke Impact
Scale as a function of study participation for the control and investiga-
tional groups. Group means and standard deviations. Analysis of variance
was P  0.001 overall, P  0.14 by group, P  0.001 by time, P  0.03
group by time.
FIGURE 4. Changes in Strength Subscore of Stroke Impact Scale as func-
tion of study participation for control and investigational groups. Group
means and standard deviations. Analysis of variance was P  0.0001
overall, P  0.0001 by group, P  0.06 by time, P  0.02 group by time.
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tions of the surgical approach when the procedure is per-
formed according to dictated protocol. Furthermore, in future
trials of this treatment, it is anticipated that the leads will not
be externalized, reducing both the risk of lead fracture and
infection. Some key clinical endpoints, such as the Fugl-Meyer
motor score, demonstrated a statistically significant gain in
relation to cortical stimulation. These are not trivial gains;
however, the full clinical significance of these findings will be
evaluated in future, larger studies that are focused on efficacy.
This safety study demonstrates that cortical stimulation can
be safely performed in a population of patients with cerebro-
vascular disease who are at risk for surgical morbidity. Pre-
liminary motor assessment data also show that intermittent
cortical stimulation delivered during periods of rehabilitation
activity does enhance upper extremity functional recovery
when compared with control groups of patients who receive
only rehabilitation. More extensive study is required to con-
firm and to clarify clinical efficacy (Figs. 2, 3, and 4).
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This study provides an interesting contribution to the field in at-tempting to address an important problem for which there is not
much to offer. Stroke is among the leading causes of disability in the
United States. Physical therapy can be beneficial, but the benefits are
limited and large numbers of patients are disabled. In this context,
developing therapies aimed at improving the recovery from stroke are
important.
The authors report a prospective randomized study to evaluate
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safety of epidural motor cortex stimulation for motor recovery from
stroke. They enrolled 10 patients randomized into a group of six
undergoing stimulation and four control patients. The surgical group
underwent the procedure guided by functional magnetic resonance
imaging (fMRI) localization of the hand and neuronavigation, epi-
dural implantation of a 33 grid centered on the fMRI hot spot,
followed by externalization of the leads with 1 week of recovery and
then stimulation at 50% of motor threshold while undergoing a
3-week rehabilitation as with the control group prior to removal of the
implants. Patients were assessed for a total of 16 weeks with various
scales. The outcome showed the control group improved average of
5% and stimulation group improved 29% which was statistically
significant. Complications included two infections and there were no
seizures.
Several factors can influence motor outcome after stroke. These
include age, location of the lesion, co-morbidities, and the time
elapsed since stroke. In the present study, the control group had more
than double the time elapsed since stroke than the group undergoing
cortical stimulation. The authors report the average time since stroke,
as well as the patients with the shortest and longest time intervals
since stroke. Evaluation of the data show that the patient with the
shortest interval was at 9 months since stroke in the investigational
group and 15 months in the control group. The patients with the
longest intervals since stroke were 33 months in the investigational
and 68 months in the control group. These large differences may
partially influence the outcomes observed in the investigational group
in relation to controls.
The authors have argued that the potential for motor recovery after
a stroke is greatest in the first weeks after the event, making the issue
of time since stroke less relevant since all patients were at least 9
months since the ictus. Nevertheless, late improvements in motor
function can be seen with rehabilitation therapy, as also evidenced by
the small improvements observed in the control group of the present
study. Thus the issue of time since stroke is important and needs to be
disclosed for all patients in conjunction with the respective outcomes.
The authors have provided an interesting contribution to the field.
The primary endpoint of the study was assessment of efficacy of this
new technique. Although two patients presented with infections in the
postoperative period, no permanent neurological damage or seizures
were associated with the therapy. Given the lack of alternatives for
this very disabled population, the results presented by the authors
indicate relative safety of motor cortex stimulation and emphasize the
importance of conducting larger prospective trials.
Andre Machado
Ali R. Rezai
Cleveland, Ohio
Sponsored by Northstar Neuroscience (Seattle, Washington), Brownet al. have demonstrated in a randomized, unblinded study im-
provements in motor function using subthreshold epidural cortical
stimulation delivered concurrently with intensive rehabilitation ther-
apy. The brain has a great deal more plasticity than we generally
think. The anecdotal observation of functional improvement in pa-
tients with implanted motor cortical stimulators (MCS) for a variety of
pain syndromes has led to some very interesting work in rehabilita-
tion. Both clinical studies and animal studies have demonstrated
considerable plasticity following stroke. This work is nicely outlined
by the authors.
There is now considerable evidence that cortical reorganization to
compensate for motor deficit occurs predominately through mecha-
nisms involving enhanced activity of pre-existing networks (3, 7, 10).
The combination of rehabilitation training with stimulation whether
peripheral, transcranial magnetic stimulation, or MCS seems to have
the ability to enhance the behavioral gains (2, 5, 6, 13). The case for
transcranial magnetic stimulation seems to be just as strong, if not
stronger than MCS (8, 9, 11, 12). In addition, even peripheral stimu-
lation may be of value (1, 4, 14).
Although a safety study, the efficiency observed is interesting.
Significant improvements were seen in the upper extremity Fugl-
Meyer and hand function scores of the Stroke Impact Scale. These
improvements were not trivial, but they were also not particularly
large. Many investigators thought that once they occur, these changes
tend to be permanent, but this remains to be determined. It would be
most interesting to follow up on these patients 1 year after rehabili-
tation to see if they maintain their improvement. Furthermore, if
internalized, MSC could be equally effective in subsequent training
episodes. Although this study was performed under intensive phys-
ical therapy, home-based self-administration also could be possible.
Such a program might be quite effective if stimulation perimeter are
subthreshold and could be routinely obtained while avoiding.
Since this study, the technology for MCS has significantly ad-
vanced. Follow-up studies have been performed and await publica-
tion. Although there is not a particularly strong placebo effect in these
types of studies, bias can always be introduced in subjective evalua-
tions. Blinded study will have to be performed at some point. With the
advances in noninvasive techniques such as transcranial magnetic
stimulation, a head-to-head comparison may be necessary before MCS
receives widespread acceptance in the rehabilitation community. The
authors are to be congratulated on this work and hopefully can
provide us with long-term follow-up.
Roy A.E. Bakay
Chicago, Illinois
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Recovery from stroke remains an elusive goal that would haveconsiderable impact on the lives of thousands of individuals who
have been so disabled. In an aging population, the need for innovative
strategies to stroke recovery is likely to increase. Brown et al. have
demonstrated relative safety of MCS in a small cohort of stroke
patients. This is a necessary first step in the investigation of a new
therapy. The absence of significant adverse effects supports the pre-
vious data of safety in patients who have received MCS in the treat-
ment of chronic pain.
However, the question of efficacy is still unresolved. The authors
have been able to demonstrate a more robust improvement in the
Fugl-Meyer scores of patients receiving stimulation. This is certainly a
very exciting result. But, as the authors themselves correctly point out,
because this study is not blinded, the possibility for a potent placebo
effect is considerable. Also worrisome is the comment that two of the
non-operated patients experienced spontaneous decreases in their
scores during the period of the study. This seems unusual in a group
of patients who are an average of 38 months out from their stroke and
should have achieved stable scores. The small size of this study is such
that an aberrant decline in one or two patients might well shift the
outcomes considerably. A larger study with patient and evaluator
blinding to stimulation will certainly be required.
The authors are to be commended for exploring this potentially
groundbreaking area with appropriate care and precision. Their dis-
cussion intelligently explores potential mechanisms by which this
treatment may be exerting an effect. As this treatment is investigated
further we may learn quite a lot about cortical plasticity and its
mechanism.
Joseph S. Neimat
Jason M. Schwalb
Andres M. Lozano
Toronto, Ontario, Canada
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